SPL Ann: DEP cabazitaxel Ph 2 trial completes enrolment & treatment - 17th Apr 2023, 10:21am

annb0t

annb0t

Top 20
SPL Ann: DEP cabazitaxel Ph 2 trial completes enrolment & treatment
Price Sensitive: N
Date: 17th Apr 2023, 10:21am

>>> Read announcement: Google: SPL Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
SPL Ann: SPL to present DEP radiotheranostics at Wilsons Conference - 26th Oct 2023, 9:26am
Replies
0
Views
100
annb0t
annb0t
annb0t
SPL Ann: Positive DEP Cabazitaxel Phase 2 Results in Multiple Cancer - 18th Oct 2023, 10:18am
Replies
0
Views
63
annb0t
annb0t
annb0t
SPL Ann: DEP irinotecan IO/PARP combination data presented at AACR - 16th Oct 2023, 11:05am
Replies
0
Views
65
annb0t
annb0t
annb0t
SPL Ann: DEP theranostic presented at international oncology meeting - 16th Oct 2023, 10:18am
Replies
0
Views
66
annb0t
annb0t
annb0t
SPL Ann: DEP irinotecan clinical data presented at AACR meeting - 16th Oct 2023, 10:02am
Replies
0
Views
90
annb0t
annb0t
Top Bottom